Ocular toxoplasmosis in immunocompetent adults: current cost-effectiveness of four treatment regimens in Colombia

Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America

(2019) Nahila Justo et al.   VALUE IN HEALTH

Quality-of-Life and Psychosocial Aspects in Patients with Ocular Toxoplasmosis: A Clinical Study in a Tertiary Care Hospital in Brazil

(2019) Aristofanes Mendonça Canamary et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up

(2016) João Paulo Fernandes Felix et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Overview of Immunodeficiency Disorders

(2015) Nikita Raje et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial

(2012) Nader Baharivand et al.   INTERNATIONAL OPHTHALMOLOGY

Therapy for Ocular Toxoplasmosis

(2011) Alejandra de-la-Torre et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Review of the Series “Disease of the Year 2011: Toxoplasmosis” Pathophysiology of Toxoplasmosis

(2011) Carlos S. Subauste et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Quality of Life Assessment in Ocular Toxoplasmosis in a Colombian Population

(2011) Alejandra de-la-Torre et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Using decision trees to enhance interdisciplinary team work: the case of oncofertility

(2010) Shauna L. Gardino et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis

(2010) Masoud Soheilian et al.   OPHTHALMOLOGY

Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis

(2008) A de-la-Torre et al.   EYE